NGM BIOPHARMACEUTICALS INC reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

NGM BIOPHARMACEUTICALS INC has filed 528 SEC EDGAR filings since 04 Feb 2008

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 351-375 of 523 matching filings.

Per page

25

Current page

15

4

FORM 4 SUBMISSION

Filing date: 06 Mar 2020
Reporting date: 05 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Mar 2020
Reporting date: 05 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Mar 2020
Reporting date: 05 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Mar 2020
Reporting date: 02 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Mar 2020
Reporting date: 02 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Mar 2020
Reporting date: 02 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Mar 2020
Reporting date: 02 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Feb 2020
Reporting date: 26 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Feb 2020
Reporting date: 26 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Feb 2020
Reporting date: 26 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Feb 2020
Reporting date: 26 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38853

8-K

Filing date: 24 Feb 2020
Reporting date: 24 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

FORM 3/A SUBMISSION

Filing date: 19 Feb 2020
Reporting date: 09 Oct 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38853

8-K

Filing date: 13 Feb 2020
Reporting date: 11 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-90978

SC 13G filing

Filing date: 11 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Feb 2020
Reporting date: 06 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Feb 2020
Reporting date: 06 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Feb 2020
Reporting date: 06 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Feb 2020
Reporting date: 06 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Feb 2020
Reporting date: 04 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Feb 2020
Reporting date: 04 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Feb 2020
Reporting date: 04 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Feb 2020
Reporting date: 04 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38853

8-K

Filing date: 13 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Jan 2020
Reporting date: 07 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .